Results 1 to 5 of 27

PTO Announces Deferred Fees for COVID-19 Applications Under New Program

USA - September 22 2020 The U.S. Patent and Trademark Office has announced that it will defer application fees for certain inventions relating to the fight against COVID-19…

Jordan Engelhardt

2019 Year-End Biosimilar Litigation Roundup

USA - December 6 2019 As 2019 draws to a close, a handful of actions regarding biologics are pending in the federal courts. The current cases are listed below, in order…

Jordan Engelhardt

Amgen Brings Third BPCIA Lawsuit Against Apotex After Losing Two Others

USA - August 8 2018 Amgen has sued Apotex in connection with Apotex’s efforts to market biosimilar versions of Amgen’s cancer drugs Neupogen (filgrastim) and Neulasta…

Irena Royzman

Federal Circuit Issues Two Decisions Impacting Standing to Challenge Validity of Pharma Patents

USA - May 23 2018 Two recent Federal Circuit decisions address when a party has standing to challenge the validity of a patent. Though the cases arose in different…

Jordan Engelhardt

Amgen and Genentech Break New Ground in Avastin Biosimilar Dispute

USA - October 26 2017 Amgen and Genentech have become embroiled in a novel procedural dispute relating to Mvasi, Amgen’s biosimilar of Genentech’s Avastin (bevacizumab). On…

Aron Fischer